Design of Screening Cardiometabolic Opportunities Using Transformative Echocardiography Artificial Intelligence (SCOUT-Echo-AI)

By afschroeder • October 20, 2026

Eusuff S, Kim J, Fatima Z, Yalcinkaya D, Sahashi Y, Sandhu A, Nguyen LH, Ambrosy AP, Cheng PP, Chang ST, Go AS, Ahmad FS, Cheung A, Cheng S, Kwan AC, Ouyang D. Design of Screening Cardiometabolic Opportunities Using Transformative Echocardiography Artificial Intelligence (SCOUT-Echo-AI). Am Heart J. 2026 Oct 19:107628. doi: 10.1016/j.ahj.2026.107628. Epub ahead of print. PMID: 42896779.

Tags: Artificial intelligence, Cardiology/Epi, Cedars Sinai DoM, Deep learning, echocardiography, Fibrotic Liver Disease, Opportunistic screening, Publications, steatotic liver disease, Veterans Administration

Timeliness of Emergency Care for Intracerebral Hemorrhage Compared With Acute Ischemic Stroke

Royan R, Ikeaba U, Alhanti B, Stamm B, Mac Grory B, Prabhakaran S, Maas MB, Fonarow GC, Messe SR, Mamer LE, Goldstein JN, Saver JL,[...]

Genetically engineering mast cells as effectors for targeted cancer cell cytotoxicity

Han X, Wen D, Fu R, Soto J, Song Y, Wu Y, Wang Z, Lin X, Yu J, Sheng T, Li S, Gu Z, He[...]

Heart failure and atrial fibrillation prediction from non-gated chest CT scans using AI-based cardiac chamber volumetry: an AI-CVD study within the multi-ethnic study of atherosclerosis (MESA)

Mirjalili SR, Atlas K, Reeves AP, Zhang C, Wasserthal J, Azimi A, Hashemi A, Mozafarybazargany M, Ghaffari Jolfayi A, Atlas T, Henschke CI, Yankelevitz DF,[...]